Allergan Aesthetics Reveals Global Layered Beauty Report
North Chicago, Illinois, USA, September 2, 2026 Allergan Aesthetics, an AbbVie company, has unveiled its new “Layered Beauty: The...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
North Chicago, Illinois, USA, September 2, 2026 Allergan Aesthetics, an AbbVie company, has unveiled its new “Layered Beauty: The...
Nashville, Tennessee, August 20, 2026 Revance and Teoxane have announced FDA approval for RHA Redensity® Eye, a hyaluronic acid...
FORT MYERS, Florida, July 2, 2026 Trilogy Laboratories has announced the acquisition of YNS Cosmeceuticals, a respected skincare brand...
ZUG, Switzerland, May 22, 2026 Galderma announced that the U.S. Food and Drug Administration (FDA) has approved the Prescription-to-Over-the-Counter...
